Pfizer, Valneva share phase 2 Lyme vax data, IN8bio axes workforce, AstraZeneca employees detained in China [The good, the bad, the ugly]
Sep 09, 2024•4 min•Ep. 57
Episode description
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — Pfizer, Valneva share phase 2 positive Lyme vax data
The bad — IN8bio axes workforce, halts trial
The ugly — AstraZeneca employees detained in China
For the best experience, listen in Metacast app for iOS or Android
